Alembic Pharmaceuticals Ltd. and Amlan International sign exclusive strategic commercial agreement to make poultry health innovations accessible to Indian farmers and integrators
Nadda noted that TB treatment coverage in India has increased from 59% to 85%
Finerenone is the first drug targeting the mineralocorticoid receptor (MR) pathway to demonstrate cardiovascular benefits in a Phase III study in patients with heart failure
This facility represents a significant step in Croda’s Pharma business strategy to ‘Empower biologics delivery’
TB treatment coverage in India increased by 32% in the last eight years from 53% in 2015 to 85% in 2023
Amifampridine Tablets, 10 mg are indicated for the treatment of Lambert-Eaton myasthenic syndrome in adults and pediatric patients 6 years of age and older.
Through strong industry cooperation, significant investment, and smart policy backing, API manufacturing may become self-reliant
Illexcor is developing a first-in-class oral drug that directly targets the root cause of SCD
Announces Rs. 317 crore investment in new recycling plant
Overall investment in the US facility is estimated around US$50 million
Subscribe To Our Newsletter & Stay Updated
